Menkes Disease Latest Advances

Find the Latest Research About Menkes Disease

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1183 publications

Copper restriction unmasks axonal degeneration in a mouse model of X-linked hereditary motor neuropathy.

Copper restriction unmasks axonal degeneration in a mouse model of X-linked hereditary motor neuropathy.

Journal: Metallomics : integrated biometal science
Published: June 05, 2026

Successful treatment of epileptic spasms with perampanel in a patient with Menkes disease caused by a novel splice variant in intron of ATP7A.

Successful treatment of epileptic spasms with perampanel in a patient with Menkes disease caused by a novel splice variant in intron of ATP7A.

Journal: Neuropediatrics
Published: May 28, 2026

Disorders Mimicking Wilson's Disease: Clinical, Biochemical, and Molecular Perspectives for Accurate Differential Diagnosis.

Disorders Mimicking Wilson's Disease: Clinical, Biochemical, and Molecular Perspectives for Accurate Differential Diagnosis.

Journal: Diagnostics (Basel, Switzerland)
Published: March 15, 2026

FDA approval of copper histidinate (Zycubo) for Menkes disease: a therapeutic breakthrough in a rare pediatric neurodegenerative disorder.

FDA approval of copper histidinate (Zycubo) for Menkes disease: a therapeutic breakthrough in a rare pediatric neurodegenerative disorder.

Journal: Annals of medicine and surgery (2012)
Published: March 09, 2026

"A new era in Menkes disease management: the disease-modifying impact of Zycubo (copper histidinate)".

"A new era in Menkes disease management: the disease-modifying impact of Zycubo (copper histidinate)".

Journal: Annals of medicine and surgery (2012)
Published: February 25, 2026

Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.

Menkes Disease: Another Example of Progress in the Development of Pharmaceuticals for Rare Childhood Diseases, But Much Still Remains to Be Done.

Journal: Clinical therapeutics
Published: February 24, 2026

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease.

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease.

Journal: The Journal of clinical investigation
Published: February 16, 2026

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease. Reply.

Concerns regarding the safety and efficacy of ES-Cu-Captisol for Menkes disease. Reply.

Journal: The Journal of clinical investigation
Published: February 16, 2026

Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis.

Distinct signaling mechanisms and proteome phenotypes are elicited by compartment-specific genetic defects of copper homeostasis.

Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026

NON-REDUNDANT ROLES OF COPPER TRANSPORTERS ATP7A AND ATP7B IN NORADRENERGIC SIGNALING.

NON-REDUNDANT ROLES OF COPPER TRANSPORTERS ATP7A AND ATP7B IN NORADRENERGIC SIGNALING.

Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026

Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.

Zycubo (copper histidinate), the first treatment for pediatric Menkes disease.

Journal: Trends in pharmacological sciences
Published: January 28, 2026

Copper-histidine therapy: a targeted metabolic intervention for Menkes disease.

Copper-histidine therapy: a targeted metabolic intervention for Menkes disease.

Journal: Annals of medicine and surgery (2012)
Published: January 21, 2026
Showing 1-12 of 1,183

Last Updated: 06/30/2026